User:Neidi: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
(New page: thumb|center|400px|Ph.D. Candidate == Contact Information == *Address: 77 Massachusetts Avenue Room 66-425, Cambridge, MA, 02139 *Office: 66-425 *Phone: (617)-2...)
 
 
(10 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:neidi.jpg|thumb|center|400px|Ph.D. Candidate]]
[[Image:neidi.jpg|thumb|right|400px]]
'''<font size="4">Neidi Negron Rodriguez, E.I.T.</font size><br>'''
''Ph.D. Candidate''<br>


== Contact Information ==
Massachusetts Institute of Technology<br>
Department of Chemical Engineering<br>
77 Massachusetts Avenue, Room 66-425<br>
Cambridge, MA 02139<br>


*Address: 77 Massachusetts Avenue Room 66-425, Cambridge, MA, 02139
*Phone:   (617)-258-8037<br>
*Office:  66-425
*Fax:     (617)-258-5042<br>
*Phone:   (617)-258-8037
*Email:    neidi@mit.edu<br>
*Email:    neidi@mit.edu


*[[Media:Resume_neidi_V08_2006.pdf|Resume]]


== Biographical Information ==
== Biographical Information ==
Line 14: Line 17:
*Birthday:    August 9
*Birthday:    August 9
*Birthplace:  Puerto Rico
*Birthplace:  Puerto Rico
*[[Media:Resume_Neidi_Negron_Rodriguez_V11_2007.pdf|My Resume]]


== Research Description ==
== Research Description ==


In many biopharmaceutical processes the use of high copy plasmids for the production of foreign proteins in host organisms is preferred in order to maximize product yields. However, the introduction of foreign genetic material directly interferes with the physiology of the host cell, altering the cell’s metabolic activities. This effect, generally known as metabolic burden, has the potential to reduce the productive capability of processes that require certain metabolites as substrates for small molecule production. In these cases, the expression level must be optimized to ensure maximum productivity. My work aims to explore the effects of changes in expression level by varying the gene dosage in a system for the production of polyphosphates (polyP) in E.coli. PolyP molecules are produced in a one-step reaction in which a terminal phosphate from an ATP molecule is transferred to a growing polyP chain by the action of the enzyme polyphosphate kinase (PPK). PolyP is ubiquitous in nature, but its production can be enhanced by the introduction and induction of additional copies of the ppk gene. Three different plasmids are used for this study: a low-copy mini-F plasmid; a medium-copy p15A type plasmid; and a high-copy pMB1 type plasmid. Measurements of copy number, mRNA levels, specific polyP content and PPK activity as a function of copy number are made during a 24-hour period. The time course experiments indicate the relationship between copy number and final product concentration and allow us to establish the optimal gene dosage for the system. The ultimate goal of this research is to derive some fundamental relationships that will allow the construction of optimal recombinant microorganisms for metabolic engineering purposes.
In many biopharmaceutical processes the use of high copy plasmids for the production of foreign proteins in host organisms is preferred in order to maximize product yields. However, the introduction of foreign genetic material directly interferes with the physiology of the host cell, altering the cell’s metabolic activities. This effect, generally known as metabolic burden, has the potential to reduce the productive capability of processes that require certain metabolites as substrates for small molecule production. In these cases, the expression level must be optimized to ensure maximum productivity. My work aims to explore the effects of changes in expression level by varying the gene dosage in a system for the production of polyphosphates (polyP) in E.coli. PolyP molecules are produced in a one-step reaction in which a terminal phosphate from an ATP molecule is transferred to a growing polyP chain by the action of the enzyme polyphosphate kinase (PPK). PolyP is ubiquitous in nature, but its production can be enhanced by the introduction and induction of additional copies of the ppk gene. Three different plasmids are used for this study: a low-copy mini-F plasmid; a medium-copy p15A type plasmid; and a high-copy pMB1 type plasmid. Measurements of copy number, mRNA levels, specific polyP content and PPK activity as a function of copy number are made during a 24-hour period. The time course experiments indicate the relationship between copy number and final product concentration and allow us to establish the optimal gene dosage for the system. The ultimate goal of this research is to derive some fundamental relationships that will allow the construction of optimal recombinant microorganisms for metabolic engineering purposes.


== Links ==
== Links ==


*[[Prather Lab|Prather Lab Homepage]]
*[[Prather Lab|Back to Prather Lab Home]]
*[[Prather:Lab_Members|Prather Lab Members]]
*[[Prather:Lab_Members|Back to Lab Members]]
*[[Prather:Protocols|Prather Lab Protocols]]

Latest revision as of 11:49, 30 November 2007

Neidi Negron Rodriguez, E.I.T.
Ph.D. Candidate

Massachusetts Institute of Technology
Department of Chemical Engineering
77 Massachusetts Avenue, Room 66-425
Cambridge, MA 02139

  • Phone: (617)-258-8037
  • Fax: (617)-258-5042
  • Email: neidi@mit.edu


Biographical Information

  • Birthday: August 9
  • Birthplace: Puerto Rico
  • My Resume

Research Description

In many biopharmaceutical processes the use of high copy plasmids for the production of foreign proteins in host organisms is preferred in order to maximize product yields. However, the introduction of foreign genetic material directly interferes with the physiology of the host cell, altering the cell’s metabolic activities. This effect, generally known as metabolic burden, has the potential to reduce the productive capability of processes that require certain metabolites as substrates for small molecule production. In these cases, the expression level must be optimized to ensure maximum productivity. My work aims to explore the effects of changes in expression level by varying the gene dosage in a system for the production of polyphosphates (polyP) in E.coli. PolyP molecules are produced in a one-step reaction in which a terminal phosphate from an ATP molecule is transferred to a growing polyP chain by the action of the enzyme polyphosphate kinase (PPK). PolyP is ubiquitous in nature, but its production can be enhanced by the introduction and induction of additional copies of the ppk gene. Three different plasmids are used for this study: a low-copy mini-F plasmid; a medium-copy p15A type plasmid; and a high-copy pMB1 type plasmid. Measurements of copy number, mRNA levels, specific polyP content and PPK activity as a function of copy number are made during a 24-hour period. The time course experiments indicate the relationship between copy number and final product concentration and allow us to establish the optimal gene dosage for the system. The ultimate goal of this research is to derive some fundamental relationships that will allow the construction of optimal recombinant microorganisms for metabolic engineering purposes.


Links